Camphor and Acyclovir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Camphor (camphor) and Acyclovir (acyclovir). Common drug interactions include dyspepsia among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Camphor and Acyclovir. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Camphor?

Camphor has active ingredients of camphor. eHealthMe is studying from 627 Camphor users. Check the latest studies of Camphor.

What is Acyclovir?

Acyclovir has active ingredients of acyclovir. It is often used in herpes simplex. eHealthMe is studying from 54,961 Acyclovir users. Check the latest studies of Acyclovir.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 20, 2026

21 people who take Camphor and Acyclovir together, and have interactions are studied.

Camphor and Acyclovir drug interactions.

What are the common drug interactions of Camphor and Acyclovir, by gender? *:

female:

  1. Dyspepsia (indigestion)
  2. Dyspnoea (difficult or laboured respiration)
  3. Dyspnoea exertional (breathlessness or shortness of breath)
  4. Emotional disorder
  5. Epistaxis (bleed from the nose)
  6. Excoriation (to tear or wear off the skin of)
  7. Eye haemorrhage (bleeding in the eye)
  8. Fall
  9. Gait disturbance
  10. Gastric ulcer (stomach ulcer)

male:

  1. Renal failure (kidney dysfunction)
  2. Abdominal compartment syndrome (increased pressure in abdomen)
  3. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  4. Multi-organ failure (multisystem organ failure)
  5. Septic shock (shock due to blood infection)
  6. Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
  7. Acute respiratory distress syndrome
  8. Hepatic congestion (liver congestion)
  9. Hypoxia (low oxygen in tissues)
  10. Pyrexia (fever)

What are the common drug interactions of Camphor and Acyclovir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Acute respiratory failure
  2. Hepatic failure (liver failure)

20-29:

  1. Gastric ulcer (stomach ulcer)
  2. Haemodynamic instability (disturbances in the blood movement in our body)
  3. Hepatic failure (liver failure)
  4. Klebsiella bacteraemia (klebsiella bacteria in blood after infection to lungs)
  5. Lactic acidosis (low ph in body tissues)
  6. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  7. Multi-organ failure (multisystem organ failure)
  8. Septic shock (shock due to blood infection)
  9. Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
  10. Acute respiratory distress syndrome

30-39:

n/a

40-49:

  1. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  2. Febrile neutropenia (fever with reduced white blood cells)

50-59:

  1. Peripheral motor neuropathy (muscles in the body become progressively weaker over months to years)
  2. Death

60+:

  1. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  2. Productive cough
  3. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  4. Anxiety
  5. Arterial disorder
  6. Arterial insufficiency (lack of enough blood flow through the arteries)
  7. Arteriosclerosis (thickening and hardening of arteries)
  8. Arthralgia (joint pain)
  9. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  10. Arthropathy

What are the existing conditions these people have? *

  1. Stress And Anxiety: 5 people, 23.81%
  2. Constipation: 4 people, 19.05%
  3. Depression: 4 people, 19.05%
  4. Multiple Myeloma (cancer of the plasma cells): 4 people, 19.05%
  5. Itching: 4 people, 19.05%
  6. Nausea (feeling of having an urge to vomit): 3 people, 14.29%
  7. Insomnia (sleeplessness): 3 people, 14.29%
  8. Fever: 3 people, 14.29%
  9. Urinary Tract Infection: 2 people, 9.52%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Camphor and Acyclovir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Camphor and Acyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Camphor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Acyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Camphor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acyclovir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on camphor and acyclovir (the active ingredients of Camphor and Acyclovir, respectively), and Camphor and Acyclovir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: